| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 25 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 25 |
| 3 | METHOTREXATE SODIUM | 24 |
| 4 | METHOTREXATE | 23 |
| 5 | TACROLIMUS | 17 |
| 6 | ETOPOSIDE | 13 |
| 7 | PREDNISONE | 12 |
| 8 | CYTARABINE | 11 |
| 9 | PREDNISOLONE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 1 | DEXRAZOXANE FOR INJECTION | 4 | 0.0042 |
| 2 | PENTOSTATIN | 4 | 0.0038 |
| 3 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 4 | CHLOROQUINE PHOSPHATE | 2 | 0.0030 |
| 5 | METEX | 1 | 0.0026 |
| 6 | THIOGUANINE | 4 | 0.0019 |
| 7 | AMIKACIN SULFATE | 2 | 0.0011 |
| 8 | ALDESLEUKIN | 1 | 0.0008 |
| 9 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Protease Inhibitor [EPC] | 15 | 0.0003 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 15 | 0.0002 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 5 | Topoisomerase Inhibitor [EPC] | 13 | 0.0002 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0001 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 25 | 0.0001 |